ImportRefusal LogoImportRefusal

BRISTOL-MYERS SQUIBB PHARMA EEIG

⚠️ Moderate Risk

FEI: 3015500897 • Dublin 15, Co. DUBLIN • IRELAND

FEI

FEI Number

3015500897

📍

Location

Dublin 15, Co. DUBLIN

🇮🇪

Country

IRELAND
🏢

Address

Blanchardstown Corporate Park 2, Plaza 254; Park 2 Ballycoolin, Dublin 15, Co. DUBLIN, Ireland

Moderate Risk

FDA Import Risk Assessment

43.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
1
Unique Violations
4/7/2020
Latest Refusal
8/13/2019
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
4/7/2020
61LCA99ANTI-COAGULANT, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/13/2019
61LCA99ANTI-COAGULANT, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is BRISTOL-MYERS SQUIBB PHARMA EEIG's FDA import refusal history?

BRISTOL-MYERS SQUIBB PHARMA EEIG (FEI: 3015500897) has 2 FDA import refusal record(s) in our database, spanning from 8/13/2019 to 4/7/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. BRISTOL-MYERS SQUIBB PHARMA EEIG's FEI number is 3015500897.

What types of violations has BRISTOL-MYERS SQUIBB PHARMA EEIG received?

BRISTOL-MYERS SQUIBB PHARMA EEIG has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about BRISTOL-MYERS SQUIBB PHARMA EEIG come from?

All FDA import refusal data for BRISTOL-MYERS SQUIBB PHARMA EEIG is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.